Krystal Biotech (KRYS) Treasury Shares (2021 - 2026)
Krystal Biotech's (KRYS) quarterly Treasury Shares came in at $310184.0 in Q1 2026, down 11.06% year-on-year from $348757.0 in Q1 2025, and down 6.45% quarter-over-quarter from $331574.0 in Q4 2025.
Krystal Biotech (KRYS) Treasury Shares (2021 - 2026) Analysis & Trends
Krystal Biotech has disclosed Treasury Shares across 6 years of filings, most recently posting $310184.0 for Q1 2026.
- Treasury Shares for Q1 2026 came in at $310184.0, down 11.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $310184.0 (down 11.06% YoY), and the FY2025 annual result was $331574.0, up 141.14% from the prior year.
- Treasury Shares came in at $310184.0 for Q1 2026 at Krystal Biotech, down from $331574.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $348757.0 in Q1 2025 to a low of $22200.0 in Q1 2024.
- The 5-year median for Treasury Shares is $137500.0 (2024), against an average of $165387.1.
- Across the five-year window, Treasury Shares plunged 50.0% in 2024 and soared 1470.98% in 2025, its largest moves.
- Krystal Biotech's Treasury Shares stood at $66600.0 in 2022, then decreased by 24.92% to $50000.0 in 2023, then jumped by 175.0% to $137500.0 in 2024, then jumped by 141.14% to $331574.0 in 2025, then slipped by 6.45% to $310184.0 in 2026.
- The last three Treasury Shares figures came in at $310184.0 (Q1 2026), $331574.0 (Q4 2025), and $338878.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Krystal Biotech | 10.23 Bn | 9.41 Bn | 110.03 Mn | 310,184.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 310,184.00 |
| Mar 31, 2026 | 310,184.00 |
| Dec 31, 2025 | 331,574.00 |
| Dec 31, 2025 | 331,574.00 |
| Jun 30, 2025 | 338,878.00 |
| Jun 30, 2025 | 338,878.00 |
| Mar 31, 2025 | 348,757.00 |
| Mar 31, 2025 | 348,757.00 |
| Dec 31, 2024 | 137,500.00 |
| Dec 31, 2024 | 137,500.00 |
| Sep 30, 2024 | 137,500.00 |
| Sep 30, 2024 | 137,500.00 |
| Jun 30, 2024 | 316,401.00 |
| Jun 30, 2024 | 316,401.00 |
| Mar 31, 2024 | 22,200.00 |
| Mar 31, 2024 | 22,200.00 |
| Dec 31, 2023 | 50,000.00 |
| Dec 31, 2023 | 50,000.00 |
| Sep 30, 2023 | 162,200.00 |
| Sep 30, 2023 | 162,200.00 |